Antimicrobial Susceptibility of Stenotrophomonas maltophilia Isolates from a Korean Tertiary Care Hospital.
10.3349/ymj.2012.53.2.439
- Author:
Hae Sun CHUNG
1
;
Seong Geun HONG
;
Yangsoon LEE
;
Myungsook KIM
;
Dongeun YONG
;
Seok Hoon JEONG
;
Kyungwon LEE
;
Yunsop CHONG
Author Information
1. Department of Laboratory Medicine and Research Institute of Bacterial Resistance, Yonsei University College of Medicine, Seoul, Korea. leekcp@yuhs.ac
- Publication Type:Brief Communication ; Research Support, Non-U.S. Gov't
- Keywords:
Stenotrophomonas maltophilia;
antimicrobial susceptibility;
trimethoprim-sulfamethoxazole;
levofloxacin;
minocycline
- MeSH:
Anti-Infective Agents/*pharmacology;
Hospitals;
Korea;
Microbial Sensitivity Tests;
Minocycline/pharmacology;
Ofloxacin/pharmacology;
Stenotrophomonas maltophilia/*drug effects;
Trimethoprim-Sulfamethoxazole Combination/pharmacology
- From:Yonsei Medical Journal
2012;53(2):439-441
- CountryRepublic of Korea
- Language:English
-
Abstract:
We determined the antimicrobial susceptibility of 90 clinical isolates of Stenotrophomonas maltophilia collected in 2009 at a tertiary care hospital in Korea. Trimethoprim-sulfamethoxazole, minocycline, and levofloxacin were active against most of the isolates tested. Moxifloxacin and tigecycline were also active and hold promise as therapeutic options for S. maltophilia infections.
